In fact, myeloid leukemia mouse model studies showed that sorafenib increases IL-15 production in FLT-ITD-positive leukemic cells which synergizes with the allogeneic CD8+ T-cell response [22]. This evidence concerns the gene IL15 and myeloid leukemia.